Projects per year
Fingerprint
Dive into the research topics where Alton Sartor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Optimization of Prostate-Specific Membrane Antigen-Targeted Radiation
Tagawa, S. T. (PI), Bander, N. H. (CoPI), Vallabhajosula, S. (CoPI), Babich, J. J. (CoPI), Ballman, K. V. (CoPI), Beltran, H. (CoPI), Jhanwar, Y. Y. (CoPI), Khani, F. (CoPI), Sartor, A. (CoPI), Harshman, L. C. (CoPI), Czernin, J. J. (CoPI) & Gnjatic, S. (CoPI)
1/1/17 → …
Project: Research project
-
PLANNING GRANT FOR LSUMC STANLEY S SCOTT CANCER CENTER
Sartor, A. (PI) & Correa, P. (CoPI)
7/1/95 → 6/30/00
Project: Research project
-
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study: Clinical Studies
O’Sullivan, J. M., Heinrich, D., Castro, E., George, S., Dizdarevic, S., Baldari, S., Essler, M., Jong, I. J. D., Lastoria, S., Hammerer, P. G., Tombal, B., James, N. D., Meltzer, J., Sandström, P. & Sartor, O., Mar 9 2025, In: British journal of cancer. 132, 4, p. 354-360 7 p., 101993.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562, (S0302283824025600), (10.1016/j.eururo.2024.08.021)]
Armstrong, A. J., Sartor, O., de Bono, J., Chi, K., Fizazi, K., Krause, B. J., Herrmann, K., Rahbar, K., Tagawa, S. T., Saad, F., Beer, T. M., Wu, J., Mirante, O. & Morris, M. J., Jun 2025, In: European urology. 87, 6, p. 738-739 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Current and future directions in theranostics for neuroendocrine prostate cancer
Belge Bilgin, G., Lucien-Matteoni, F., Chaudhuri, A. A., Orme, J. J., Childs, D. S., Muniz, M., Li, G. G., Chauhan, P. S., Lee, S. B., Gupta, S., Thorpe, M. P., Johnson, D. R., Johnson, G. B., Kendi, A. T. & Sartor, O., May 2025, In: Cancer Treatment Reviews. 136, 102941.Research output: Contribution to journal › Review article › peer-review
-
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
Clarke, N. W., Armstrong, A. J., Oya, M., Shore, N., Procopio, G., Daniel Guedes, J., Arslan, C., Mehra, N., Parnis, F., Brown, E., Schlürmann, F., Young Joung, J., Sugimoto, M., Sartor, O., Poehlein, C., McGuinness, D., Degboe, A. & Saad, F., Apr 1 2025, In: European Urology Oncology. 8, 2, p. 394-406 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
Chauhan, P. S., Alahi, I., Sinha, S., Ledet, E. M., Mueller, R., Linford, J., Shiang, A. L., Webster, J., Greiner, L., Yang, B., Ni, G., Dang, H. X., Saha, D., Babbra, R. K., Feng, W., Harris, P. K., Qaium, F., Duose, D. Y., Alexander, S. E. & Sherry, A. D. & 11 others, , Jan 1 2025, In: Clinical Cancer Research. 31, 1, p. 151-163 13 p.Research output: Contribution to journal › Article › peer-review